Down-regulation of 14-3-3ζ suppresses anchorage-independent growth of lung cancer cells through anoikis activation
- Zenggang Li*,
- Jing Zhao*,
- Yuhong Du*,
- Hae Ryoun Park*,†,
- Shi-Yong Sun‡,
- Leon Bernal-Mizrachi‡,
- Alastair Aitken§,
- Fadlo R. Khuri‡, and
- Haian Fu*,‡,¶
- *Department of Pharmacology and
- ‡Winship Cancer Institute, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322; and
- §Institute of Structural Biology, University of Edinburgh School of Biological Sciences, Kings Buildings, Edinburgh EH9 3JR, United Kingdom
-
Communicated by R. John Collier, Harvard Medical School, Boston, MA, November 19, 2007 (received for review September 5, 2007)
Abstract
The family of 14-3-3 proteins has emerged as critical regulators of diverse cellular responses under both physiological and pathological conditions. Here, we report an important role of 14-3-3ζ in tumorigenesis through a mechanism that involves anoikis resistance. 14-3-3ζ is up-regulated in a number of cancer types, including lung cancer. Through an RNAi approach using human lung adenocarcinoma-derived A549 cells as a model system, we have found that knockdown of a single ζ isoform of 14-3-3 is sufficient to restore the sensitivity of cancer cells to anoikis and impair their anchorage-independent growth. Enhanced anoikis appears to be mediated in part by up-regulated BH3-only proteins, Bad and Bim, coupled with decreased Mcl-1, resulting in the subsequent activation of Bax. This study suggests a model in which anchorage-independent growth of lung cancer cells requires the presence of 14-3-3ζ. This work not only reveals a critical role of 14-3-3ζ in anoikis suppression in lung cancer cells, but also identifies and validates 14-3-3ζ as a potential molecular target for anticancer therapeutic development.
Footnotes
- ¶To whom correspondence should be addressed. E-mail: hfu{at}emory.edu
-
Author contributions: F.R.K. and H.F. designed research; Z.L., J.Z., Y.D., H.R.P., and L.B.-M. performed research; S.-Y.S. and A.A. contributed new reagents/analytic tools; Z.L., J.Z., Y.D., H.R.P., S.-Y.S., F.R.K., and H.F. analyzed data; and Z.L., F.R.K., and H.F. wrote the paper.
-
↵ †Present address: Department of Oral Pathology, School of Dentistry, Pusan National University, Pusan 602-739, South Korea.
-
The authors declare no conflict of interest.
-
This article contains supporting information online at www.pnas.org/cgi/content/full/0710905105/DC1.
-
Freely available online through the PNAS open access option.
- © 2007 by The National Academy of Sciences of the USA





